ADiTx Inc (ADTX): He was pimping it on bb's board when it...

Next 10 Prev Next

Send PM Follow Ignore

Followers	98
Posts	26667
Boards Moderated	0
Alias Born	04/08/2005

nwsun

Re: shoondale post# 546

Friday, 01/10/2025 12:53:41 PM

Friday, January 10, 2025 12:53:41 PM

He was pimping it on bb's board when it was .19 .20 then it dumped to .15 shortly thereafter.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ADTX News

Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2026 09:03:44 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2026 08:31:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:20:52 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 08:20:06 PM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026 • Business Wire • 05/14/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:20:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:35:47 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/23/2026 08:30:42 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/22/2026 04:15:21 AM
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients • Business Wire • 04/20/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2026 12:00:13 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/11/2026 01:49:19 AM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/07/2026 08:02:58 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/03/2026 08:37:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 01:13:36 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:35:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 12:00:37 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/27/2026 09:02:12 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/24/2026 09:21:36 PM
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer • Business Wire • 03/19/2026 12:15:00 PM
Aditxt Acquires Ignite Proteomics to Expand Precision Oncology Capabilities • IH Market News • 03/13/2026 03:36:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2026 12:35:24 PM
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection • Business Wire • 03/13/2026 12:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:30:35 PM
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 • Business Wire • 03/05/2026 01:30:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ADTX News

More ADTX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ADTX News

Go Ad-Free